The following table sets forth the calculation of basic and diluted net loss per share attributable to common stockholders during the three and nine months ended September 30, 2022 and 2021:


	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Net loss attributable to Nuvve common stockholders	$	(8,403,247)	$	(6,976,580)	$	(69,072,863)	$	(18,525,606)
Weighted-average shares used to compute net loss per share attributable to Nuvve common stockholders, basic and diluted	21,952,882		18,627,978		19,972,016		15,931,466
Net Loss per share attributable to Nuvve common stockholders, basic and diluted	$	(0.38)	$	(0.37)	$	(3.46)	$	(1.16)

The following outstanding shares of common stock equivalents were excluded from the calculation of the diluted net loss per share attributable to Nuvve common stockholders because their effect would have been anti-dilutive:


	Three Months Ended September 30,		Nine Months Ended September 30,
	2022	2021	2022	2021
Stock options issued and outstanding	2,649,652	2,890,564	2,624,818	2,342,967
Nonvested restricted stock issued and outstanding	1,117,868	832,757	952,068	667,297
Public warrants	2,875,000	2,875,000	2,875,000	2,061,121
Private warrants	136,250	136,250	136,250	97,679
PIPE warrants	1,353,750	1,353,750	1,353,750	970,519
Stonepeak and Evolve warrants	6,000,000	6,000,000	6,000,000	3,000,000
Stonepeak and Evolve options	5,000,000	5,000,000	5,000,000	2,500,000
Institutional/Accredited Investor Pre-Funded Warrants	869,674	—	293,077	—
Institutional/Accredited Investor Warrants	2,739,130	—	923,077	—

Total	22,741,324	19,088,321	20,158,040	11,639,583